Related Experiment Video
Updated: Jul 28, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Reduced DNA-dependent protein kinase activity is associated with lung cancer
D H Auckley1, R E Crowell, E R Heaphy
1Division of Pulmonary, Critical Care and Allergy, University of New Mexico and the New Mexico Veterans Health Care System, Albuquerque, NM 87108, USA.
Abstract:
Reduced DNA repair capacity of carcinogen-induced DNA damage is now thought to significantly influence inherent susceptibility to lung cancer. DNA-dependent protein kinase (DNA-PK) is a serine-threonine kinase activated by the presence of double-strand breaks in DNA that appears to play a major role in non-homologous recombination and transcriptional control. The purpose of this study was to determine whether DNA-PK activity varies among individuals and how this affects lung cancer risk. DNA-PK activity in peripheral mononuclear cells from individuals with lung cancer (n = 41) was compared with lung cancer-free controls (n = 41). Interindividual variability was seen within each group, however, significant differences (P = 0.03) in DNA-PK activity between cases and controls were seen when comparing the distribution of enzyme activity among these two groups. The percentages of cases and controls with DNA-PK activity in the ranges 2.5-5.0 and 7.6-10.0 units were 39 versus 20% and 7 versus 29%, respectively. The enzyme activity in peripheral mononuclear cells reflected that seen in bronchial epithelial cells, one progenitor cell for lung cancer, supporting the use of peripheral mononuclear cells for larger population-based studies of DNA-PK activity. Its role as a potential modifier for lung cancer risk was supported by the fact that cell growth in bronchial epithelial cells exposed to bleomycin was directly associated with enzyme activity. The results of this study demonstrate that reduced DNA-PK repair activity is associated with risk for lung cancer.
Insights
Reduced DNA repair capacity, specifically DNA-dependent protein kinase (DNA-PK) activity, is linked to increased lung cancer risk. Lower DNA-PK activity in individuals correlates with a higher susceptibility to developing lung cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Reduced DNA repair capacity for carcinogen-induced DNA damage is a key factor in inherent susceptibility to lung cancer.
- DNA-dependent protein kinase (DNA-PK) is a critical enzyme involved in DNA double-strand break repair and transcriptional control.
Purpose of the Study:
- To investigate interindividual variations in DNA-PK activity.
- To determine the association between DNA-PK activity levels and lung cancer risk.
Main Methods:
- DNA-PK activity was measured in peripheral mononuclear cells (PMNs) from lung cancer patients (n=41) and healthy controls (n=41).
- Enzyme activity in PMNs was correlated with activity in bronchial epithelial cells.
- The effect of DNA-PK activity on bronchial epithelial cell growth after bleomycin exposure was assessed.
Main Results:
- Significant differences in DNA-PK activity distribution were observed between lung cancer cases and controls (P=0.03).
- Fewer cases than controls exhibited high DNA-PK activity (7-10 units), while more cases had low to moderate activity (2.5-5.0 units).
- DNA-PK activity in PMNs accurately reflected that in bronchial epithelial cells, validating PMNs as a suitable biomarker.
Conclusions:
- Reduced DNA-PK activity is associated with an increased risk of lung cancer.
- DNA-PK activity may serve as a potential modifier of lung cancer risk.
- Peripheral mononuclear cells are a viable surrogate for studying DNA-PK activity in population-based lung cancer research.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
The JAK-STAT Signaling Pathway